# Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali

> **NCT05081089** · PHASE2 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 80 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **DRUG:** Artemether-lumefantrine
- **DRUG:** Primaquine Phosphate
- **DRUG:** Sulphadoxine-pyrimethamine with amodiaquine
- **DRUG:** Tafenoquine

## Key facts

- **NCT ID:** NCT05081089
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-12
- **Primary completion:** 2021-12-16
- **Final completion:** 2022-01-13
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05081089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05081089, "Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05081089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*